Enochian Biosciences, Inc.
Hedge Funds Holdings
Last updated:
Enochian Biosciences, Inc.‘s stocks are currently a part of 25 hedge funds’ portfolios, which represents 18.4% of the total amount of its stocks outstanding. This makes up a total of 1.75M shares of Enochian Biosciences, Inc.. Compared to the previous quarter, the number fell by -51.71% or -1.87M shares fewer. As for the holding position changes, 36% (9) of current hedge fund investors increased the number of shares held, 28% (7) of current holders sold a part of the shares held, and 8% (2) closed the holdings completely. 5 hedge funds are new holders of Enochian Biosciences, Inc. stock in Q1 2023, it is 20% of total holders.
Hedge funds holding Enochian Biosciences (Q4 2018 – Q1 2023)
| Q4 2018 | 2 |
|---|---|
| Q1 2019 | 18 |
| Q2 2019 | 29 |
| Q3 2019 | 29 |
| Q4 2019 | 33 |
| Q1 2020 | 32 |
| Q2 2020 | 33 |
| Q3 2020 | 38 |
| Q4 2020 | 40 |
| Q1 2021 | 40 |
| Q2 2021 | 31 |
| Q3 2021 | 29 |
| Q4 2021 | 43 |
| Q1 2022 | 41 |
| Q2 2022 | 47 |
| Q3 2022 | 38 |
| Q4 2022 | 39 |
| Q1 2023 | 25 |
Hedge funds changes in Enochian Biosciences positions (Q4 2018 – Q1 2023)
| Q4 2018 | 2 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 17 | 0 | 0 | 1 | 0 |
| Q2 2019 | 16 | 6 | 5 | 5 | -3 |
| Q3 2019 | 4 | 9 | 10 | 4 | 2 |
| Q4 2019 | 8 | 18 | 1 | 4 | 2 |
| Q1 2020 | 2 | 14 | 8 | 3 | 5 |
| Q2 2020 | 4 | 12 | 7 | 3 | 7 |
| Q3 2020 | 7 | 8 | 11 | 2 | 10 |
| Q4 2020 | 6 | 13 | 12 | 4 | 5 |
| Q1 2021 | 4 | 17 | 11 | 4 | 4 |
| Q2 2021 | 9 | 3 | 18 | 18 | -17 |
| Q3 2021 | 9 | 7 | 11 | 11 | -9 |
| Q4 2021 | 20 | 10 | 6 | 6 | 1 |
| Q1 2022 | 9 | 15 | 12 | 11 | -6 |
| Q2 2022 | 23 | 15 | 9 | 16 | -16 |
| Q3 2022 | 5 | 14 | 13 | 14 | -8 |
| Q4 2022 | 5 | 14 | 12 | 4 | 4 |
| Q1 2023 | 5 | 9 | 7 | 2 | 2 |
Hedge funds changes in Enochian Biosciences stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 205,000 | 74,000 |
| Q4 2021 | 124,000 | 0 |
| Q1 2022 | 234,000 | 26,000 |
| Q2 2022 | 384,000 | 666,000 |
| Q3 2022 | 115,000 | 5,000 |
| Q4 2022 | 13,081 | 26,780 |
| Q1 2023 | 0 | 0 |